Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Scinai Immunotherapeutics(SCNI) the Revenue is 460 K (+146%);the EBIT is -2.146 M (+2.23%);the EPS is -1.77 (+91.39%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B145.99%
----
----
EBIT
-0.00B2.23%
----
----
EPS
-1.771391.39%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf